AAV-mediated transfer of FKRP shows therapeutic efficacy in a murine model but requires control of gene expression

Autor: William J. Martin, Steven J. Foltz, Karine Charton, Nathalie Bourg, Aaron M. Beedle, Evelyne Gicquel, Isabelle Richard, Natacha Maizonnier, Fedor Svinartchouk
Přispěvatelé: Approches génétiques intégrées et nouvelles thérapies pour les maladies rares (INTEGRARE), Université d'Évry-Val-d'Essonne (UEVE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Généthon-École pratique des hautes études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL), University of Georgia [USA], École pratique des hautes études (EPHE)-Université d'Évry-Val-d'Essonne (UEVE)-GENETHON 3-Institut National de la Santé et de la Recherche Médicale (INSERM), École Pratique des Hautes Études (EPHE), Université Paris sciences et lettres (PSL)-Université Paris sciences et lettres (PSL)-Université d'Évry-Val-d'Essonne (UEVE)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Généthon
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
Glycosylation
[SDV.BIO]Life Sciences [q-bio]/Biotechnology
Gene Expression
medicine.disease_cause
Muscular Dystrophies
Mice
chemistry.chemical_compound
0302 clinical medicine
Gene expression
Muscular dystrophy
Dystroglycans
Laminin binding
Genetics (clinical)
ComputingMilieux_MISCELLANEOUS
Mice
Knockout

Mutation
Fukutin-related protein
Articles
General Medicine
LGMD
Cell biology
FKRP
Protein Binding
Biology
Abnormal glycosylation
03 medical and health sciences
Muscle Dystrophy
Transferases
Genetics
medicine
Animals
Pentosyltransferases
Muscle
Skeletal

Molecular Biology
Pentosephosphates
Proteins
Genetic Therapy
medicine.disease
Fukutin
Disease Models
Animal

030104 developmental biology
Gene Expression Regulation
Muscular Dystrophies
Limb-Girdle

chemistry
biology.protein
Protein Processing
Post-Translational

030217 neurology & neurosurgery
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Zdroj: Human Molecular Genetics
Human Molecular Genetics, Oxford University Press (OUP), 2017, 26 (10), pp.1952-1965. ⟨10.1093/hmg/ddx066⟩
Human Molecular Genetics, 2017, 26 (10), pp.1952-1965. ⟨10.1093/hmg/ddx066⟩
ISSN: 0964-6906
1460-2083
DOI: 10.1093/hmg/ddx066⟩
Popis: Limb Girdle Muscular Dystrophies type 2I (LGMD2I), a recessive autosomal muscular dystrophy, is caused by mutations in the Fukutin Related Protein (FKRP) gene. It has been proposed that FKRP, a ribitol-5-phosphate transferase, is a participant in α-dystroglycan (αDG) glycosylation, which is important to ensure the cell/matrix anchor of muscle fibers. A LGMD2I knock-in mouse model was generated to express the most frequent mutation (L276I) encountered in patients. The expression of FKRP was not altered neither at transcriptional nor at translational levels, but its function was impacted since abnormal glycosylation of αDG was observed. Skeletal muscles were functionally impaired from 2 months of age and a moderate dystrophic pattern was evident starting from 6 months of age. Gene transfer with a rAAV2/9 vector expressing Fkrp restored biochemical defects, corrected the histological abnormalities and improved the resistance to eccentric stress in the mouse model. However, injection of high doses of the vector induced a decrease of αDG glycosylation and laminin binding, even in WT animals. Finally, intravenous injection of the rAAV-Fkrp vector into a dystroglycanopathy mouse model due to Fukutin (Fktn) knock-out indicated a dose-dependent toxicity. These data suggest requirement for a control of FKRP expression in muscles.
Databáze: OpenAIRE